Authors
Latest:
Episode 144: Differentiating Dravet and Lennox-Gastaut: Diagnosis, Research, and What’s AheadMind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Joseph Sullivan, MD. [LISTEN TIME: 14 minutes]
Latest:
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersAdvocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
Latest:
Optical Coherence Tomography Angiography Helps Differentiate MS and NMOSDAlthough existing research has shown structural differences between multiple sclerosis and neuromyelitis optica spectrum disorder in following optic neuritis, the new report also covers non–optic neuritis eyes.
Latest:
Exploring Genetic Variants and Global Challenges in Alzheimer Disease Research: Jeffery M. Vance, MD, PhDThe professor of human genetics at the University of Miami discussed the significance of various genetic factors in Alzheimer risk and highlighted ongoing research, therapeutic challenges as well as the need for global collaboration. [WATCH TIME: 10 minutes]
Latest:
Results from the Subgroup Analysis of BECOME Caregiver Survey: Robert Iannone, MD, MSCEThe executive vice president of Global Head of Research and Development at Jazz Pharmaceuticals, spoke on the results from the BECOME study presented at the 2022 AES Conference. [WATCH TIME: 6 minutes]
Latest:
Advice for Physicians and the Multiple Sclerosis CommunityThe panel shares final advice for the multiple sclerosis community.
Latest:
Mitchell Miglis, MD: A Bidirectional Link Between Autonomic Dysfunction, HypersomniasThe autonomic disorders and sleep medicine specialist at Stanford University spoke about the overlap of autonomic disorders in sleep medicine, an often underrepresented portion of the sleep medicine field.
Latest:
Tools and Resources for the Management of MSDrs Jeffrey Dunn and Regina Berkovich review available tools and resources for the care of patients with multiple sclerosis, focusing on specific symptoms.
Latest:
James W. Wheless, MD: Making Treatment Decisions in EpilepsyThe professor and chief of pediatric neurology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center discussed the decision-making process for choosing interventions for patients with epilepsy, and how to keep patients adherent.
Latest:
Harald Hampel, MD, PhD, MA, MSc on Advancements and Challenges in the Alzheimer SpaceHampel looks to the future of the Alzheimer space and sees promise, especially since there’s transfertilization from other advanced science fields in medicine like oncology, diabetes research and rheumatology.
Latest:
The Frequency of Occurrence of Narcolepsy SymptomsDrs Thorpy, Dogan, Doghramji, and Kushida discuss the frequency of symptoms encountered in patients who are diagnosed with narcolepsy.
Latest:
What to Expect at MDA’s 2025 Clinical and Scientific Conference: Barry J. Byrne, MD, PhDThe chief medical advisor at the Muscular Dystrophy Association shared key highlights of what attendees can expect at the 2025 MDA Clinical and Scientific Conference. [WATCH TIME: 4 minutes]
Latest:
Kathryn Davis, MD, MSTR: Off-Label Clobazam Use in Refractory EpilepsyThe associate professor of neurology and medical director of the epilepsy monitoring unit and Penn epilepsy surgical program at the University of Pennsylvania discussed the findings of a single-center review of off-label clobazam use for patients with drug-refractory epilepsy.
Latest:
Dennis Lal, PhD: The Value of Genetic TestingIn an interview with NeurologyLive, Dennis Lal, PhD, discusses the value of genetic testing and how it can optimize the way we develop clinical trials and test new therapies.
Latest:
The Changing Landscape of Preventative Migraine TreatmentsA panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.
Latest:
Therapeutic Optimization of Stiripentol for Dravet Syndrome: James Wheless, MD, FAAP, FAAN, FAESThe Le Bonheur Chair in Pediatric Neurology at the University of Tennessee Health Science Center highlighted the benefits and challenges of using stiripentol, an FDA-approved treatment for Dravet syndrome. [WATCH TIME: 4 minutes]
Latest:
Stroke Risk Increase in Women With Elevated Lifetime Estrogen ExposureResults from a recent study suggest that greater cumulative exposure to estrogen throughout a woman’s lifespan could increase her risk of stroke.
Latest:
Advancing the Treatment of Pediatric Migraine With Nerivio REN Wearable: Klaus Werner, MD & Alon IroniThe pediatric neurologist at Duke Health and chief executive officer at Theranica talked about a remote electrical neuromodulation wearable that showed promising results for the treatment and prevention of migraine in pediatric patients. [WATCH TIME: 5 minutes]
Latest:
The Approval of Fenfluramine for Treating Dravet SyndromeTwo experts explain the impact of the drug fenfluramine’s FDA approval in the treatment of Dravet syndrome.
Latest:
Building a Neurology Space Inclusive of Diversity and Equity: Daniel Correa, MD, MScThe neurologist at Montefiore Medical Center, Albert Einstein College of Medicine, discussed his experience in establishing a neurology department committee on diversity, equity, and inclusion. [WATCH TIME: 5 minutes]
Latest:
Elizabeth Gerard, MD: Considering Genetic Testing for Adult EpilepticsThe associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine discussed the reasons an adult with epilepsy may seek genetic testing and what benefits it can provide.
Latest:
Achieving Consensus Definitions for Refractory and Resistant Migraine: Jennifer Robblee, MD, MScThe headache neurologist at the Barrow Neurological Institute talked about an international expert panel that established agreed-upon definitions for refractory and resistant migraine. [WATCH TIME: 4 minutes]
Latest:
Long-Term CBD Use Appears Safe for Patients With Lennox-Gastaut SyndromeThe section chief of pediatric neurology at Nationwide Children’s Hospital shared his excitement about the approval of Epidiolex and its potential as a therapeutic.
Latest:
Doctors, Remember Your CallingIt’s hard to be in medicine at the moment, and one day’s recognition is not enough. As your peer, I honor my fellow physicians today and every day.
Latest:
Tal Arbel, PhD: Approaching Multiple Sclerosis with Machine LearningThe director of the probabilistic vision group and medical imaging lab at McGill University spoke about how these learning methods can be used to predict future lesion activity and disability progression in MS.
Latest:
Steven Shook, MD: Managing Patients Via TelemedicineThe staff neurologist, Vice-Chair of Operations, and Quality Improvement Officer at Cleveland Clinic Neurological Institute detailed his experience managing patients with various conditions through a telemedicine platform.
